# Novel mRNA cancer vaccine cuts melanoma recurrence risk in major study

https://mins.news/en/item/112975

- CBC News, 2026-10-23 15:10 UTC
- Health
- Original: https://www.cbc.ca/news/health/moderna-mrna-melanoma-vaccine-9.7393062?cmp=rss

> Results from a major study released Thursday by Moderna and Merck show that a first-of-its-kind cancer vaccine significantly reduces the chances of melanoma tumors returning.

## Related coverage

- [Oncologists applaud melanoma data as Moderna shares tumble](https://mins.news/en/item/113297) — Bloomberg News, 2026-10-23
- [Personalized mRNA melanoma vaccine cuts recurrence risk in late-stage trial](https://mins.news/en/item/113238) — NBC News, 2026-10-23
- [Doctors call Moderna and Merck cancer vaccine data a major advance despite Wall Street reaction](https://mins.news/en/item/113063) — CNBC, 2026-10-23
- [Cancer vaccine lowers risk of melanoma tumors returning](https://mins.news/en/video/111892) — The Associated Press, 2026-10-22